DNA methylation in osteoarthritic chondrocytes: a new molecular target

Osteoarthritis and Cartilage

Volumn 15, Issue 2, 2007, Pages 128-137

  Roach, H I ^a   Aigner, T ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cartilage articular; DNA methylation; Epigenetics; Inflammatory cytokines; Matrix metalloproteases; Osteoarthritis

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ARTICLE; CARTILAGE CELL; DEMETHYLATION; DNA METHYLATION; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HERITABILITY; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDLINE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PUBLICATION; TRANSCRIPTION REGULATION;

CHONDROCYTES; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; OSTEOARTHRITIS;

EID: 33846393572     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.07.002     Document Type: Article

References (85)

1. Aigner T., and Dudhia J. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann Rheum Dis 56 (1997) 287-291
2. Aigner T., Reichenberger E., Bertling W., Kirsch T., Stoss H., and Von der M.K. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 63 (1993) 205-211
3. Walker G.D., Fischer M., Gannon J., Thompson Jr. R.C., and Oegema Jr. T.R. Expression of type-X collagen in osteoarthritis. J Orthop Res 13 (1995) 4-12
4. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 52 (2005) 3110-3124
5. Davis C.D., and Uthus E.O. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229 (2004) 988-995
6. Liu L., Wylie R.C., Andrews L.G., and Tollefsbol T.O. Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124 (2003) 989-998
7. Rountree M.R., Bachman K.E., Herman J.G., and Baylin S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 20 (2001) 3156-3165
8. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15 (2005) 490-495
9. Fang J.Y., and Lu Y.Y. Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol 8 (2002) 400-405
10. Attwood J.T., Yung R.L., and Richardson B.C. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 59 (2002) 241-257
11. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., and Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10 (2001) 687-692
12. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl (2003) 245-254
13. Urnov F.D., and Wolffe A.P. Above and within the genome: epigenetics past and present. J Mammary Gland Biol Neoplasia 6 (2001) 153-167
14. Pradhan S., and Esteve P.O. Mammalian DNA (cytosine-5) methyltransferases and their expression. Clin Immunol 109 (2003) 6-16
15. Detich N., Ramchandani S., and Szyf M. A conserved 3′-untranslated element mediates growth regulation of DNA methyltransferase 1 and inhibits its transforming activity. J Biol Chem 276 (2001) 24881-24890
16. Leonhardt H., Rahn H.P., and Cardoso M.C. Intranuclear targeting of DNA replication factors. J Cell Biochem Suppl 30-31 (1998) 243-249
17. Bachman K.E., Rountree M.R., and Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 276 (2001) 32282-32287
18. Ortmann C.A., Burchert A., Holzle K., Nitsche A., Wittig B., Neubauer A., et al. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region. Nucleic Acids Res 33 (2005) 6895-6905
19. Lucarelli M., Fuso A., Strom R., and Scarpa S. The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J Biol Chem 276 (2001) 7500-7506
20. Furukawa Y., Sutheesophon K., Wada T., Nishimura M., Saito Y., Ishii H., et al. Methylation silencing of the Apaf-1 gene in acute leukemia. Mol Cancer Res 3 (2005) 325-334
21. Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 88 (2003) 899-910
22. Kass S.U., Landsberger N., and Wolffe A.P. DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol 7 (1997) 157-165
23. Kass S.U., Pruss D., and Wolffe A.P. How does DNA methylation repress transcription?. Trends Genet 13 (1997) 444-449
24. Chan M.F., Liang G., and Jones P.A. Relationship between transcription and DNA methylation. Curr Top Microbiol Immunol 249 (2000) 75-86
25. Wade P.A. Methyl CpG-binding proteins and transcriptional repression. BioEssays 23 (2001) 1131-1137
26. Hendrich B., and Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19 (2003) 269-277
27. Zlatanova J. MeCP2: the chromatin connection and beyond. Biochem Cell Biol 83 (2005) 251-262
28. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23 (1999) 58-61
29. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
30. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., and Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21 (1999) 103-107
31. Cervoni N., and Szyf M. Demethylase activity is directed by histone acetylation. J Biol Chem 276 (2001) 40778-40787
32. Mutskov V., and Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 23 (2004) 138-149
33. Roach HI, Inglis S, Partridge KA, Clarke NMP, Oreffo ROC, Bronner F. Can changes in the DNA methylation pattern explain the clonally inherited altered phenotype of osteoarthritic chondrocytes? In: Proceedings of the Eighth International Conference on the Chemistry and Biology of Mineralized Tissues, Banff, Canada, 2005, pp 192-5.
34. Yuasa Y. DNA methylation in cancer and ageing. Mech Ageing Dev 123 (2002) 1649-1654
35. Brandeis M., Frank D., Keshet I., Siegfried Z., Mendelsohn M., Nemes A., et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371 (1994) 435-438
36. Silke J., Rother K.I., Georgiev O., Schaffner W., and Matsuo K. Complex demethylation patterns at Sp1 binding sites in F9 embryonal carcinoma cells. FEBS Lett 370 (1995) 170-174
37. Antequera F., and Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A 90 (1993) 11995-11999
38. Robertson K.D., Hayward S.D., Ling P.D., Samid D., and Ambinder R.F. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15 (1995) 6150-6159
39. Bird A. The essentials of DNA methylation. Cell 70 (1992) 5-8
40. Boyes J., and Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 11 (1992) 327-333
41. Nan X., Meehan R.R., and Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21 (1993) 4886-4892
42. Wolffe A.P., Jones P.L., and Wade P.A. DNA demethylation. Proc Natl Acad Sci U S A 96 (1999) 5894-5896
43. Morgan H.D., Santos F., Green K., Dean W., and Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 14 Spec No 1 (2005) R47-R58
44. Mayer W., Niveleau A., Walter J., Fundele R., and Haaf T. Demethylation of the zygotic paternal genome. Nature 403 (2000) 501-502
45. Santos F., and Dean W. Epigenetic reprogramming during early development in mammals. Reproduction 127 (2004) 643-651
46. Kress C., Thomassin H., and Grange T. Local DNA demethylation in vertebrates: how could it be performed and targeted?. FEBS Lett 494 (2001) 135-140
47. Ramchandani S., Bhattacharya S.K., Cervoni N., and Szyf M. DNA methylation is a reversible biological signal. Proc Natl Acad Sci U S A 96 (1999) 6107-6112
48. Bhattacharya S.K., Ramchandani S., Cervoni N., and Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397 (1999) 579-583
49. Jost J.P., Siegmann M., Sun L., and Leung R. Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem 270 (1995) 9734-9739
50. Zhu B., Zheng Y., Hess D., Angliker H., Schwarz S., Siegmann M., et al. 5-Methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. Proc Natl Acad Sci U S A 97 (2000) 5135-5139
51. Zhu B., Zheng Y., Angliker H., Schwarz S., Thiry S., Siegmann M., et al. 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res 28 (2000) 4157-4165
52. Vairapandi M. Characterization of DNA demethylation in normal and cancerous cell lines and the regulatory role of cell cycle proteins in human DNA demethylase activity. J Cell Biochem 91 (2004) 572-583
53. Duerr S., Stremme S., Soeder S., Bau B., and Aigner T. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin Exp Rheumatol 22 (2004) 603-608
54. Soeder S, Roach HI, Oehler S, Bau B, Haag J, Aigner T. MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin Exp Rheumatol, in press.
55. Fraser A., Fearon U., Reece R., Emery P., and Veale D.J. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44 (2001) 2024-2028
56. Freemont A.J., Hampson V., Tilman R., Goupille P., Taiwo Y., and Hoyland J.A. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 56 (1997) 542-549
57. Tetlow L.C., and Woolley D.E. Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro. Osteoarthritis Cartilage 9 (2001) 423-431
58. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., and Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 97 (1996) 2011-2019
59. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., and McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44 (2001) 2777-2789
60. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., and Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46 (2002) 2648-2657
61. Nagase H., and Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 5 (2003) 94-103
62. Nguyen Q., Mort J.S., and Roughley P.J. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 89 (1992) 1189-1197
63. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14 (2006) 13-29
64. Aigner T., Rose J., Martin J., and Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res 7 (2004) 134-145
65. Fan Z., Bau B., Yang H., and Aigner T. IL-1beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkappaB signaling pathways. Cytokine 28 (2004) 17-24
66. Fernandes J.C., Martel-Pelletier J., and Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39 (2002) 237-246
67. Goldring S.R., and Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res (2004) S27-S36
68. Malemud C.J. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 18 (2004) 23-35
69. Tetlow L.C., Adlam D.J., and Woolley D.E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44 (2001) 585-594
70. Hmadcha A., Bedoya F.J., Sobrino F., and Pintado E. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med 190 (1999) 1595-1604
71. Abramson S.B., Attur M., Amin A.R., and Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3 (2001) 535-541
72. Studer R., Jaffurs D., Stefanovic-Racic M., Robbins P.D., and Evans C.H. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 7 (1999) 377-379
73. Poschl E., Fidler A., Schmidt B., Kallipolitou A., Schmid E., and Aigner T. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis 64 (2005) 477-480
74. Kim Y.I., Logan J.W., Mason J.B., and Roubenoff R. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J Lab Clin Med 128 (1996) 165-172
75. Huhtala P., Tuuttila A., Chow L.T., Lohi J., Keski-Oja J., and Tryggvason K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266 (1991) 16485-16490
76. Richardson B. Impact of aging on DNA methylation. Ageing Res Rev 2 (2003) 245-261
77. Lopatina N., Haskell J.F., Andrews L.G., Poole J.C., Saldanha S., and Tollefsbol T. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 84 (2002) 324-334
78. Nilsson O., Mitchum Jr. R.D., Schrier L., Ferns S.P., Barnes K.M., Troendle J.F., et al. Growth plate senescence is associated with loss of DNA methylation. J Endocrinol 186 (2005) 241-249
79. Hsieh C.L. Evidence that protein binding specifies sites of DNA demethylation. Mol Cell Biol 19 (1999) 46-56
80. Thomassin H., Flavin M., Espinas M.L., and Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 20 (2001) 1974-1983
81. Kirillov A., Kistler B., Mostoslavsky R., Cedar H., Wirth T., and Bergman Y. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet 13 (1996) 435-441
82. Granet C., Maslinski W., and Miossec P. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 6 (2004) R190-R198
83. Liacini A., Sylvester J., Li W.Q., and Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21 (2002) 251-262
84. Auron P.E. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev 9 (1998) 221-237
85. Saklatvala J., Dean J., and Clark A. Control of the expression of inflammatory response genes. Biochem Soc Symp (2003) 95-106